Altitude Ventures Management, LLC
SEC exempt reporting adviser (venture capital exemption).
- Website
- HTTP://WWW.ALTITUDELSV.COM/
- HQ
- WA
Altitude Ventures Management is a venture firm that seeks early stage life science companies in markets with significant demand and growth potential. Its team includes Managing Partner Dave Maki and Partner Kristen Wong. The firm's portfolio spans areas such as RNA therapeutics, gene editing, neuroscience, microbiome work, and AI-driven science.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Series B, Growth, Series A |
| Sectors | Biotech | Not enough dated deals | Biotech, Healthtech, Life sciences and research tools, Advanced materials |
| Regions | Not stated | Not enough dated deals | CA, MA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2006 | 1 | Biotech, Healthtech |
| 2007 | 1 | Biotech, Healthtech |
| 2008 | 2 | Biotech, Devtools, Healthtech |
| 2009 | 3 | Biotech, Advanced materials, Devtools |
| 2010 | 2 | Biotech, Advanced materials, Healthtech |
| 2011 | 3 | Biotech, Healthtech, Advanced materials |
| 2012 | 1 | Advanced materials, Biotech |
| 2013 | 1 | Biotech, Healthtech |
| 2015 | 2 | Biotech, Healthtech |
| 2016 | 3 | Biotech, Healthtech, AI applications |
| 2017 | 3 | Biotech, Healthtech |
| 2018 | 3 | Biotech, Life sciences and research tools, Healthtech |
| 2019 | 5 | Biotech, Healthtech, AI applications |
| 2020 | 3 | Biotech, Life sciences and research tools, Healthtech |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2010 | 0 | 0 | 1 | 1 | 0 |
| 2011 | 0 | 0 | 0 | 2 | 1 |
| 2012 | 0 | 0 | 0 | 0 | 1 |
| 2013 | 0 | 0 | 0 | 1 | 0 |
| 2014 | 0 | 0 | 0 | 0 | 0 |
| 2015 | 0 | 0 | 0 | 1 | 0 |
| 2016 | 0 | 0 | 2 | 1 | 0 |
| 2017 | 0 | 0 | 0 | 1 | 1 |
| 2018 | 0 | 0 | 0 | 1 | 1 |
| 2019 | 0 | 0 | 1 | 3 | 1 |
| 2020 | 0 | 0 | 2 | 0 | 1 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Altitude Life Science Ventures Fund IV, L.P. | approx. 2020 | $150M (Form D) | Follow-ons only |
03 · People across funds
- David Maki, Manager of the General Partner of the Issuer
Altitude Life Science Ventures Fund IV, L.P. (Named on Form D)
- Dave Maki, Managing Partner
- Kristen Wong, Partner
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://WWW.ALTITUDELSV.COM/
- https://www.altitudelsv.com/contact-4
- https://www.altitudelsv.com/fund-ii
- https://www.altitudelsv.com/team
- https://www.altitudelsv.com/fund-iv
- https://www.altitudelsv.com/about
- https://www.altitudelsv.com/fund-iii
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026